Detalhe da pesquisa
1.
Safety and Pharmacokinetics of a Four Monoclonal Antibody Combination Against Botulinum C and D Neurotoxins.
Antimicrob Agents Chemother
; 63(12)2019 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31591130
2.
Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics.
PLoS One
; 17(6): e0267796, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657812
3.
A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques.
Med
; 3(3): 188-203.e4, 2022 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35132398
4.
Neutralizing Concentrations of Anti-Botulinum Toxin Antibodies Positively Correlate with Mouse Neutralization Assay Results in a Guinea Pig Model.
Toxins (Basel)
; 13(9)2021 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34564675
5.
A Monoclonal Antibody Combination against both Serotypes A and B Botulinum Toxin Prevents Inhalational Botulism in a Guinea Pig Model.
Toxins (Basel)
; 13(1)2021 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33466411
6.
Pharmacokinetics of Human Recombinant Anti-Botulinum Toxin Antibodies in Rats.
Toxins (Basel)
; 11(6)2019 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31212950
7.
Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model.
Toxins (Basel)
; 11(4)2019 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30959899
8.
An ambient temperature-stable antitoxin of nine co-formulated antibodies for botulism caused by serotypes A, B and E.
PLoS One
; 13(5): e0197011, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29746518